Ibuprofen
(eye-BYOO-pro-fen)
Trade Name(s):
Advil
Tablets 200 mg
Advil Liqui-Gels
Capsules 200 mg
Advil Migraine
Capsules 200 mg
Children's Advil
Tablets, chewable 50 mg
Suspension 100 mg/5 mL
Children's Motrin
Tablets, chewable 50 mg
Suspension 100 mg/5 mL
Genpril
Tablets 200 mg
Haltran
Tablets 200 mg
Infant's Motrin
Oral drops 40 mg/mL
Junior Strength Advil
Tablets, chewable 100 mg
Junior Strength Motrin
Tablets 100 mgTablets, chewable 100 mg
Menadol
Tablets 200 mg
Midol Maximum Strength Cramp Formula
Tablets 200 mg
Motrin
Tablets 400 mgTablets
600 mgTablets 800 mg
Motrin IB
Tablets 200 mg
Motrin Migraine Pain
Tablets 200 mg
Nuprin
Tablets 200 mg
PediaCare Fever
Suspension 100 mg/5 mL
Oral drops 40 mg/mL
Pediatric Advil Drops
Suspension 100 mg/2.5 mL
Actiprofen
Alti-Ibuprofen
Apo-Ibuprofen
Novo-Profen
Nu-Ibuprofen
Indicates Canadian trade names.
Class: Analgesic
NSAID
Action:
Decreases inflammation, pain, and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.
Indications:
Relief of symptoms of rheumatoid arthritis, osteoarthritis, mild-to-moderate pain, primary dysmenorrhea, reduction of fever.
Unlabeled use(s):Symptomatic treatment of juvenile rheumatoid arthritis, sunburn, resistant acne vulgaris.
Contraindications:
Hypersensitivity to aspirin, iodides, or any other NSAID.
Route/Dosage:
Rheumatoid Arthritis and Osteoarthritis
Adults:
PO
300 to 800 mg tid to qid, not to exceed 3.2 g/day.
Mild-to-Moderate Pain
Adults:
PO
400 mg q 4 to 6 hr prn.
Primary Dysmenorrhea
Adults:
PO
400 mg q 4 hr prn.
Juvenile Arthritis
Children:
PO
30 to 40 mg/kg/day in 3 to 4 divided doses.
Fever Reduction
Children 1 to 12 yr:
39.2°C (102.5°F) recommended dose
PO 5 mg/kg;
> 39.2°C (102.5°F) recommended dose
PO 10 mg/kg;
max daily dose 40 mg/kg.
OTC Use (Minor Aches/Pains, Dysmenorrhea, Fever Reduction)
PO
200 mg q 4 to 6 hr. Do not exceed 1.2 g in 24 hr or take for pain for
> 10 days or for fever for > 3 days, unless directed by health care provider. Use smallest effective dose.
Interactions:
Beta-blockers:
Antihypertensive effect may be decreased.
Digoxin:
Ibuprofen may increase digoxin serum levels.
Lithium:
May increase lithium levels.
Loop diuretics:
Diuretic effects may be decreased.
Methotrexate:
May increase methotrexate levels.
Warfarin:
May increase risk of gastric erosion and bleeding.
Lab Test Interferences:
None well documented.
Adverse Reactions:
- CV:
- Peripheral edema; water retention; worsening or precipitation of CHF.
- CNS:
- Dizziness; lightheadedness; drowsiness; vertigo; headaches; aseptic meningitis.
- DERM:
- Rash; pruritus; erythema.
- EENT:
- Visual disturbances; photophobia; tinnitus.
- GI:
- Gastric distress; occult blood loss; diarrhea; vomiting; nausea; heartburn;
dyspepsia; anorexia; constipation; abdominal distress/cramps/pain; flatulence;
indigestion; GI tract fullness.
- GU:
- Menometrorrhagia; hematuria; cystitis; acute renal insufficiency; interstitial nephritis; hyperkalemia; hyponatremia; renal papillary necrosis.
- OTHER:
- Muscle cramps.
Precautions:
Pregnancy:
Undetermined.
Lactation:
Undetermined.
Children:
Safety and efficacy not established.
Elderly:
Increased risk of adverse reactions.
GI effects:
Serious GI toxicity (eg, bleeding, ulceration, perforation) can occur at any time, with or without warning symptoms.
Renal effects:
Increased risk of dysfunction in patients with preexisting renal disease.
Patient Care Considerations
Administration/Storage:
- Give medication soon after meals or with food, milk, or antacids to minimize GI irritation.
Assessment/Interventions:
- Obtain complete patient history, including drug history and any known allergies.
- Notify health care provider if visual changes or indications of GI distress or liver or renal impairment occur.
- Monitor patient's following cardiac status: BP, pulse (eg, quality and rhythm), edema, tachycardia, palpitations.
- Assess renal function before and during therapy. Monitor serum creatinine, Ccr, and BUN in patients with renal impairment.
- Document any changes in liver function (AST, ALT), eye examinations, and Hgb and Hct in patients on long-term therapy.
- Notify health care provider if indigestion, epigastric pain, unusual bleeding or bruising, or dark tarry stools occur.
OVERDOSAGE: SIGNS & SYMPTOMS Drowsiness, lethargy, GI irritation/bleeding, nausea, vomiting, tinnitus, sweating, acute renal failure, epigastric pain, metabolic acidosis
|
Patient/Family Education:
- Tell patient to take medication soon after meals or with food, milk, or antacids.
- Tell patient to avoid alcohol and medications containing aspirin, such as cold remedies.
- Advise patient to discontinue drug and notify health care provider if any of the following occur: persistent GI upset or headache, skin rash, itching, visual disturbances, black stools, weight gain or edema, changes in urine pattern, joint pain, fever, blood in urine.
- Instruct patient not to take otc preparation for > 3 days for fever and > 10 days for pain and to notify health care provider if condition does not improve.
- Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness.
AtoZ Drug Facts · Copyright©2000 by Facts and Comparisons